Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 17888-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#17888-1-AP, RRID:AB_2147741
- Product name
- MXD1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated MXD1 antibody (Cat. #17888-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references HOXA5 inhibits the proliferation of extrahepatic cholangiocarcinoma cells by enhancing MXD1 expression and activating the p53 pathway.
A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expression.
The MicroRNA-382-5p/MXD1 Axis Relates to Breast Cancer Progression and Promotes Cell Malignant Phenotypes.
MXD1 regulates the imatinib resistance of chronic myeloid leukemia cells by repressing BCR-ABL1 expression.
Mxd1 mediates hypoxia-induced cisplatin resistance in osteosarcoma cells by repression of the PTEN tumor suppressor gene.
miR-19a/b modulates lung cancer cells metastasis through suppression of MXD1 expression.
Xiong F, Liu W, Wang X, Wu G, Wang Q, Guo T, Huang W, Wang B, Chen Y
Cell death & disease 2022 Sep 27;13(9):829
Cell death & disease 2022 Sep 27;13(9):829
A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expression.
Holmes AG, Parker JB, Sagar V, Truica MI, Soni PN, Han H, Schiltz GE, Abdulkadir SA, Chakravarti D
Science advances 2022 Apr 29;8(17):eabh3635
Science advances 2022 Apr 29;8(17):eabh3635
The MicroRNA-382-5p/MXD1 Axis Relates to Breast Cancer Progression and Promotes Cell Malignant Phenotypes.
Zhang X, Zhao H, Zhang Y, Yang X, Zhang J, Yi M, Zhang C
The Journal of surgical research 2020 Feb;246:442-449
The Journal of surgical research 2020 Feb;246:442-449
MXD1 regulates the imatinib resistance of chronic myeloid leukemia cells by repressing BCR-ABL1 expression.
Huan C, Jin L, Heng W, Na A, Yuming P, Xin D, Qiaoxia Z
Leukemia research 2018 Dec;75:1-6
Leukemia research 2018 Dec;75:1-6
Mxd1 mediates hypoxia-induced cisplatin resistance in osteosarcoma cells by repression of the PTEN tumor suppressor gene.
Zheng D, Wu W, Dong N, Jiang X, Xu J, Zhan X, Zhang Z, Hu Z
Molecular carcinogenesis 2017 Oct;56(10):2234-2244
Molecular carcinogenesis 2017 Oct;56(10):2234-2244
miR-19a/b modulates lung cancer cells metastasis through suppression of MXD1 expression.
Hu W, Jin P, Ding C, Liu W
Oncology letters 2016 Sep;12(3):1901-1905
Oncology letters 2016 Sep;12(3):1901-1905
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The MXD1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human MXD1. This antibody recognizes human, mouse, rat antigen. The MXD1 antibody has been validated for the following applications: ELISA, WB analysis.